# Continuous Subcutaneous Infusion of Pramlintide and Insulin

> **NCT00291772** · PHASE4 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 13 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Pramlintide

## Key facts

- **NCT ID:** NCT00291772
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291772, "Continuous Subcutaneous Infusion of Pramlintide and Insulin". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00291772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*